Koers Sirona Biochem Corp. Other OTC
Aandelen
SRBCF
CA82967M1005
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 672K 488K 452K | Omzet 2023 | 34,78K 25,25K 23,4K | Marktkapitalisatie | 21,44 mln. 15,56 mln. 14,42 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,18 mln. -2,02 mln. | Nettowinst (verlies) 2023 | -2 mln. -1,45 mln. -1,35 mln. | EV/omzet 2022 | 48,8 x |
Nettoschuld 2022 | 48,04K 34,87K 32,32K | Nettoschuld 2023 | 1,61 mln. 1,17 mln. 1,08 mln. | EV/omzet 2023 | 663 x |
K/w-verhouding 2022 |
-8,81
x | K/w-verhouding 2023 |
-8,43
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 89,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19-10-06 |
Director of Finance/CFO | - | 29-04-09 | |
Chief Tech/Sci/R&D Officer | - | 31-03-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19-10-06 |
Alex Marazzi
BRD | Director/Board Member | - | 19-10-06 |
Director of Finance/CFO | - | 29-04-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+51,85% | 57,87 mld. | |
+41,42% | 40,25 mld. | |
-5,25% | 39,94 mld. | |
-5,16% | 28,54 mld. | |
+12,79% | 26,4 mld. | |
-20,18% | 19,33 mld. | |
+30,88% | 12,4 mld. | |
+0,61% | 12,23 mld. | |
+25,06% | 12,2 mld. |